Prevalence and predictors of trichomonas infection in newly incarcerated women

Sexually Transmitted Diseases

Volumn 39, Issue 12, 2012, Pages 973-978

  Nijhawan, Ank E ^a   Chapin, Kimberle C ^b   Salloway, Rachel ^c   Andrea, Sarah ^b   Champion, Jessi ^d   Roberts, Mary ^c   Clarke, Jennifer G ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYTICAL EQUIPMENT; CLINICAL ASSESSMENT; COMPUTER ASSISTED DIAGNOSIS; CONFERENCE PAPER; DEMOGRAPHY; ETHNICITY; FEMALE; GENE AMPLIFICATION; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PAPANICOLAOU TEST; PREDICTOR VARIABLE; PREVALENCE; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PRISONERS; REAGENT KITS, DIAGNOSTIC; RHODE ISLAND; RISK FACTORS; SELF CARE; SELF REPORT; SEXUAL BEHAVIOR; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; VAGINA; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 84870253582     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31826e8847     Document Type: Conference Paper

References (30)

1. Centers for Disease Control and Prevention. STD fact sheetV Trichomonas. Available at: http://www.cdc.gov/std/trichomonas/stdfact-trichomoniasis.htm. Accessed March, 12, 2012.
2. Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol 2009; 200(2):188.e181-188.e187.
3. Cotch MF, Pastorek JG 2nd, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24(6):353-360.
4. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195(5):698-702.
5. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7(1):95-102.
6. Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis 2007; 45(10): 1319-1326.
7. Ginocchio CC, Chapin K, Smith JS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the APTIMA(R) Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol 2012; 50(8):2601-2608.
8. Miller M, Liao Y, Gomez AM, et al. Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs. J Infect Dis 2008; 197(4):503-509.
9. Cu-Uvin S, Ko H, Jamieson DJ, et al. Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)Ypositive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis 2002; 34(10): 1406-1411.
10. Gaydos CA, Hsieh YH, Barnes M, et al. Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after Internet recruitment. Sex Transm Dis 2011; 38(9):828-832.
11. Nijhawan AE, DeLong AK, Celentano DD, et al. The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women. Sex Transm Dis 2011; 38(12): 1094-1100.
12. Freeman AH, Katz KA, Pandori MW, et al. Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay. Sex Transm Dis 2010; 37(3):165-168.
13. Andrea SB, Chapin KC. Comparison of APTIMATrichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: Performance parameters and epidemiological implications. J Clin Microbiol 2011; 49(3):866-869.
14. Sutcliffe S, Newman SB, Hardick A, et al. Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates. Sex Transm Dis 2010; 37(9):585-590.
15. Sorvillo F, Smith L, Kerndt P, et al. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7(6):927-932.
16. Centers for Disease Control and Prevention. STD rates by race or ethnicity. Available at: http://www.cdc.gov/std/health-disparities/race.htm. Accessed March 5, 2012.
17. Adimora AA, Schoenbach VJ. Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis 2005; 191(suppl 1):S115YS122.
18. Sabol W, Minton D, Harrison P. Bureau of Justice Statistics Bulletin: Prison and jail inmates at midyear 2006. National Criminal Justice. 2007; NCJ 217675:1-22. Available at: http://www.ojp.usdoj.gov/bjs/abstract/pjim06.htm. Accessed March, 12, 2012.
19. Kissinger P, Amedee A, Clark RA, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis 2009; 36:11-16.
20. Centers for Disease Control and Prevention. HIV surveillance in women. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/slides/women/ index.htm. Accessed March, 12, 2012.
21. Chesson HW, Blandford JM, Pinkerton SD. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis 2004; 31(9): 547-551.
22. Munson E, Napierala M, Basile J, et al. Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions. Diagn Microbiol Infect Dis 2010; 68(1):66-72.
23. ACOG Committee on Practice BulletinsYGynecology. ACOG Practice Bulletin no. 109: Cervical cytology screening. Obstet Gynecol 2009; 114(6):1409-1420.
24. Clarke JG, Phipps M, Rose J, et al. Follow-up of abnormal pap smears among incarcerated women. J Correctional Health Care 2007; 13(1):22-26.
25. Nijhawan AE, Salloway R, Nunn AS, et al. Preventive healthcare for underserved women: Results of a prison survey. J Womens Health (Larchmt) 2010; 19(1):17-22.
26. Lara-Torre E, Pinkerton JS. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolaou smear. Am J Obstet Gynecol 2003; 188(2):354-356.
27. Chapin K, Andrea S. APTIMA(R) Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens. Expert Rev Mol Diagn 2011; 11(7):679-688.
28. Ghanem KG, Hutton HE, Zenilman JM, et al. Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sex Transm Infect 2005; 81(5):421-425.
29. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005; 32(12):725-728.
30. Rathod SD, Krupp K, Klausner JD, et al. Bacterial vaginosis and risk for Trichomonas vaginalis infection: A longitudinal analysis. Sex Transm Dis 2011; 38(9):882-886.